[{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 79, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": 688750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 77, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 652500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 56, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 69, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 64, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 571375, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 70, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.15, "open": 1.16, "dayLow": 1.14, "dayHigh": 1.16, "regularMarketPreviousClose": 1.15, "regularMarketOpen": 1.16, "regularMarketDayLow": 1.14, "regularMarketDayHigh": 1.16, "payoutRatio": 0.0, "beta": 1.347, "forwardPE": 6.0526314, "volume": 235204, "regularMarketVolume": 235204, "averageVolume": 641247, "averageVolume10days": 264630, "averageDailyVolume10Day": 264630, "bid": 1.11, "ask": 1.18, "bidSize": 1, "askSize": 1, "marketCap": 19564020, "fiftyTwoWeekLow": 0.65, "fiftyTwoWeekHigh": 13.5, "allTimeHigh": 937.5, "allTimeLow": 0.65, "fiftyDayAverage": 1.3039, "twoHundredDayAverage": 1.68251, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 17858924, "profitMargins": 0.0, "floatShares": 16519348, "sharesOutstanding": 17012191, "sharesShort": 1033868, "sharesShortPriorMonth": 658545, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0608, "heldPercentInsiders": 0.028970001, "heldPercentInstitutions": 0.05459, "shortRatio": 2.22, "shortPercentOfFloat": 0.0626, "impliedSharesOutstanding": 17012191, "bookValue": 4.495, "priceToBook": 0.25583982, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -40990540, "trailingEps": -4.87, "forwardEps": 0.19, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToEbitda": -0.434, "52WeekChange": -0.90818363, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 1.15, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 6089126, "totalCashPerShare": 0.358, "ebitda": -41137704, "totalDebt": 1881651, "quickRatio": 0.117, "currentRatio": 0.475, "debtToEquity": 2.785, "returnOnAssets": -0.22879, "returnOnEquity": -0.54696, "freeCashflow": 18358088, "operatingCashflow": -20584636, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Citius Pharmaceuticals, Inc.", "longName": "Citius Pharmaceuticals, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.15, "corporateActions": [], "postMarketTime": 1758930160, "regularMarketTime": 1758916801, "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.15, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "1.14 - 1.16", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 641247, "fiftyTwoWeekLowChange": 0.5, "fiftyTwoWeekLowChangePercent": 0.7692308, "fiftyTwoWeekRange": "0.65 - 13.5", "fiftyTwoWeekHighChange": -12.35, "fiftyTwoWeekHighChangePercent": -0.91481483, "fiftyTwoWeekChangePercent": -90.81837, "dividendDate": 1496966400, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.87, "epsForward": 0.19, "epsCurrentYear": -2.08, "priceEpsCurrentYear": -0.55288464, "fiftyDayAverageChange": -0.15390003, "fiftyDayAverageChangePercent": -0.11803055, "twoHundredDayAverageChange": -0.53251004, "twoHundredDayAverageChangePercent": -0.3164974, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]